Ribociclib-d6 hydrochloride

• CAT Number: S000014
• Molecular Formula: C23H25D6ClN8O
• Molecular Weight: 477.04
• Purity: ≥95%
• Target: CDK
• IUPAC Name: 7-cyclopentyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]-N,N-bis(trideuteriomethyl)pyrrolo[2,3-d]pyrimidine-6-carboxamide;hydrochloride
• InChI: InChI=1S/C23H30N8O.ClH/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30;/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28);1H/i1D3,2D3
• InChIKey: JZRSIQPIKASMEV-TXHXQZCNSA-N
• SMILES: [2H]C([2H])([2H])N(C(=O)C1=CC2=CN=C(N=C2N1C3CCCC3)NC4=NC=C(C=C4)N5CCNCC5)C([2H])([2H])[2H].Cl

Ribociclib-d6 Hydrochloride is a high-purity deuterated compound used in advanced pharmaceutical research. This isotopically labeled version of Ribociclib is essential for studies involving CDK4/6 inhibitors, cancer therapeutics, pharmacokinetics, and metabolic pathways. Featuring six deuterium atoms, it ensures precise and reliable analytical results. The hydrochloride salt form enhances solubility and stability, making it suitable for various experimental setups. Ideal for oncology research and drug development, Ribociclib-d6 Hydrochloride integrates seamlessly into existing protocols, offering a robust and cost-effective solution for high-precision scientific investigations.